CPAP alternative Bongo Rx hits market

Friday, May 10, 2019

DEERFIELD BEACH, Fla. – AirAvant Medical says its flagship product, Bongo Rx, is now available for patients requiring treatment for mild to moderate obstructive sleep apnea. The Bongo Rx, cleared by the U.S. Food and Drug Administration, seals comfortably in the nose and works by creating back pressure when an OSA sufferer exhales. “For compliant CPAP patients, the Bongo Rx may provide a supplemental treatment option to complement their lifestyle,” said Javier Collazo, vice president. “For non-compliant patients, the Bongo Rx may provider a patient friendly, non-cumbersome treatment option to get them refocused and re-engaged on treating their obstructive sleep apnea.” AirAvant previewed the Bongo Rx at Medtrade in October.